Differentiating Between Type 1 and 2 Diabetes Mellitus

     Diabetes mellitus is a group of metabolic disorders characterized by inadequate insulin secretion by the pancreas or cellular destruction leading to an insulin deficiency. Depending on the cause of the insulin shortage, diabetes can be subcategorized into type I and type II. Type I diabetes (T1DM) is usually mediated by the destruction of b-cells in the pancreas resulting in decreased insulin production and secretion. Type II diabetes (T2DM) is the failure of these b-cells to secrete adequate amounts of insulin to compensate for insulin resistance and increased gluconeogenesis combined with an overall resistance to the insulin action (8., 1997). T2DM accounts

Type two diabetes is the most common disease today, and it has a great impact on the lives of many people in the United States. Type two diabetes results when the body is resistant to insulin or impaired secretion of insulin by the pancreatic beta cells. The pancreas produces too much insulin, but over time it is not able to make an adequate amount of insulin needed in order to move the glucose into the cells. However, there are many factors that lead to type two diabetes. They are known to be genetic, high body weight, previously identified impaired fasting glucose levels or impaired glucose tolerance, family history of diabetes, and history of gestational diabetes or delivery of a baby over 9 pounds. Type two diabetes effects about 90% to 95% of the cases of disease in the US (Hinkle & Cheever, 2013). It's

Diabetes Mellitus (DM) or Type 2 Diabetes is seen as a metabolic disease that is categorized by abnormally high blood glucose or hyperglycemia. Diabetes Mellitus is also formerly known as noninsulin-dependent diabetes mellitus and is the most common form of diabetes that is seen. Insulin is a hormone that is supplied to the body that allows us to efficiently use glucose as fuel. When carbohydrates are broken down into sugars in the stomach glucose enters the blood circulation simulating the pancreas to release insulin in an appropriate amount to become used for energy. With diabetes mellitus the body does not properly make use of the insulin supplied for the body. This causes the pancreas to produced an extra amount if insulin which the body cannot keep up with, causing an imbalance to the blood glucose levels (American Diabetes Association, 2015). In the united states diabetes affects almost 29.1 million people, while the another 86 million people have pre-diabetes but do not know. It is also known as the 7th leading cause of death in the country in the recent years (MedicineNet.com, 2016). For a patient suffering from a chronic form of diabetes mellitus understanding how these mechanisms lead to the condition can be used as preventative measures. Potential consequences as well as the causes and clinical manifestations will ensure a better knowledge on the issue to monitor the condition.

Diabetes is a metabolic disease where an individual’s blood glucose level is higher than normal standards. Diabetes is a long term condition that causes not only primary issues related to the disease but secondary problems as well. Diabetes also known and referred to by healthcare professionals as diabetes mellitus, which is a phrase used to describe a group of metabolic diseases in which a person’s body does not produce insulin at all, or a person’s body does not use insulin properly, which is called insulin resistance. Type I Diabetes also known as juvenile diabetes is when the body does not produce insulin, approximately 10% of all diabetes cases are type I. Type 2 diabetes is when the body does not use insulin properly and approximately 90% of all documented cases worldwide is of this type. (American Diabetes Association, 2014) All types of diabetes can be treated, type I has no known cure however there have been some cases where

Diabetes mellitus, is the fancy way to say diabetes but many people referred it as diabetes. Diabetes is a group of metabolic diseases which can cause you to have high blood sugar levels over a long period. The two main types of diabetes are type 1 and type 2. Type 1 results from the pancreas's failure to produce enough insulin. This form was previously referred to as "insulin-dependent diabetes mellitus" or "juvenile diabetes". The cause is unknown. Type 2 begins with insulin resistance, a condition in which the cells fail to respond to insulin properly. There is no known preventive for type 1 diabetes, Or Type 2 diabetes which accounts for 85-90% of all cases can often be prevented or delayed by maintaining a normal body weight, engaging

There are three differences between type 1 and type 2 diabetes in diagnosis, cause, and symptoms. One difference between type 1 and 2 is in diagnosis. The possible cause factors in type 1 are environmental, autoimmune, and idiopathic, while cause factors in type 2 are obesity, physical activity, and high or low weight. Therefore, type 1 diabetes is mostly diagnosed in children and teenagers, whereas type 2 diabetes is usually diagnosed in adults. Other difference between type 1 and 2 is the cause. Type 1 is caused by the immune system which destroys cells that release insulin causing total lack of insulin, so cells cannot absorb glucose, blood sugar. Unlike type 1, type 2 diabetes is caused by an insulin resistance from the body leading pancreas

Type1 and type2 diabetes are treatment and both have the same symptoms. Diabetes, a disease that has spread recently greatly annoying a disease accompanied by symptoms including. His where the patient feels at times of weakness or loss of appetite. A higher proportion of sugar in the blood to exit the fluid out of the body tissues, including the eye lenses, which causes poor visibility. On the other hand, it is known that physical exercise is an important factor in health status in general, which is an integral part of the treatment of diabetes. Sports determining the factor for the health of some of their age and size. So reduce regular exercise, including daily activities risk of diabetes. In summary type1 and type2 diabetes can not be fully

This project seeks to provide a brief overview of what a new drug has to go through before it hits the streetsstarting with the manufacture, preclinical or clinical trials, documentation, registration, review, approval, marketing, &distribution; focusing on tests they have to hurdle. Another aim would be to identifya drug that binds itself to the SGLT2 & inhibits its function. The researcher has found that Dapagliflozin of the Gliflozin class of antidiabetic medications is anSGLT2 inhibitor. This paper will define keywords, explain the action, enumerate preclinical &clinical trials that have to be undergone before the FDA deems it safe for human consumption; with the ultimate goal of getting the product approved, marketed, &distributed in the US& elsewhere. There are no participants [animal or human] in this report. This

Invokana (canagliflozin) is an oral diabetic medication used to help control blood sugar levels in type 2 diabetics. Type 2 diabetes is a condition, usually with an onset in adulthood, in which the body cannot make enough insulin. Canagliflozin works with the kidneys to help get rid of glucose from the bloodstream. (drugs.com, 2015) It is suggested that with a healthy diet and adequate exercise this medication has the ability to control type 2 diabetes.

The differences between Type 1 and Type 2 diabetes is Type 1 is an autoimmune condition. It's because the body starts attacking it pancreas with antibodies. Type 1 diabetes is an insulin dependent diabetes. Type 2 diabetes is the most common type of diabetes. With type 2 diabetes your pancreas usually produces insulin. The amount it produces isn't enough for the body needs. There is no cure for diabetes. Type 2 can be controlled. (WebMD,2018) It will affect her quality of life because she will have to stop eating fatty foods and eat healthier. She will also have to do more walking so she can lose weight. I recommend she change her diet and take a healthier approach with her life. She would also have to accept that she has diabetes, so she

There are two types of diabetes mellitus: Type 1 diabetes (T1D) and Type 2 diabetes (T2D). T1D is characterized by the inability to produce adequate insulin. T2D, which is more prevalent, is characterized by insulin resistance primarily due to fatty diets and sedentary lifestyles72,73. Sufficient insulin production and/or supplementation is vital to maintaining a healthy female

Type-2 diabetes is the most common form of diabetes. It is a condition where the pancreas does not produce enough insulin due to high blood sugars (glucose) or the cells found in the body do not respond to insulin. In some cases it can be a combination of both. Everyone needs glucose in their blood but if sugar levels are higher than a normal range it can damage your body over time and if these bloods sugars aren’t kept under control it can be life-threatening.

Canagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2. It also glucose to be filtered through the kidney and excreted through urine. Being that the glucose is excreted through urine rather than taken into the bloodstream, it helps to lower blood sugar levels in the blood of type 2 diabetics.

The article published by American Journal of Nursing discussed about a case report and evidence in choosing among available drugs for the patient that has diabetes mellitus. In December 2012, it was reported that there are merely 26.9 % of people aged 65 and above living in the United States has been diagnosed with diabetes. Also, it is stated that there are about 13.7 % of American ages 45-64 and 2 million people ages 20 and older have the disease.

Introduction: Invokana and Forixga are sodium-glucose co-transporter 2 (SGLT2) inhibitors, a indicated as an adjunct to diet, exercise as well as other concomitant anti diabetic medications to improve glycemic control in adults with type 2 diabetes mellitus. This new class of agent developed as oral diabetic medication was studied for effectiveness and safety. An Improved glycaemic control and weight loss has been demonstrated in clinical trials but effectiveness outside of the trial environment has not yet reported.